MarketInOut Stock Screener Log In | Sign Up

Ind-Swift Laboratories Ltd

Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/28/2026 15:58
Ind-Swift Laboratories Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Market Capitalization28,934 mln
Float40.14 mln
Earnings Date10/29/2026

EPS

6.69
Stretched

P / E

56.64
Richly valued

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-2.18
Caution advised

Relative Strength

92 / 100
Top performer

Debt / Equity

0.01
Debt-free

Business Description

Ind-Swift Laboratories Limited is an India-based pharmaceutical company founded in 1995 that produces and sells active drug ingredients, intermediates, and finished medicines to customers both at home and abroad. The company covers a wide range of medical conditions, from heart disease and diabetes to cancer and neurological disorders. It also offers contract research and manufacturing services, along with reference standards and chemical impurities used in pharmaceutical testing and development.

Key Fundamentals

EPS6.69
P/E56.64
ROE4.44
RPS76.42
ROIC2.25
ROA3.65
Interest Cover8.22
EBITDA, mln1,062
EV / EBITDA29.77
EV / EBIT42.34
Revenue, mln6,647
EV / Revenue4.75

Quote Details

Last 378.95
Change 10.15 (2.75%)
Open 376.20
Volume 589,736
Turnover 223,480,464
Average Volume 488,238

Financial Ratios

Pre-Tax Profit Margin11
Current Ratio3.80
Price / Book2.45
Price / Tangible Book2.49
Debt / Equity0.01
Price / Sales4.99

Financial Strength

Altman Z-Score7.93
Piotroski F-Score 4 / 9
Beneish M-Score-2.18
Price to Intrinsic Value8.49
Price to Graham Number2.84
Shiller PE Ratio28.90

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 10.64% 97 / 100   
1 Month -6.28% 55 / 100   
2 Months 59.49% 98 / 100   
6 Months 182% 99 / 100   
1 Year 274% 100 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog